Page 56 - JSOM Fall 2018
P. 56

TABLE 2  Pre- and Posttransfusion Thromboelastogram Values
                          R (s)            K (s)              (°)              M (mm)             Lys30
                                                                                 a
                     BL      T+60      BL      T+60      BL       T+60      BL      T+60       BL      T+60
           Gravity  4.85 ± 2.3  4.2 ± 2.6  1.3 ± 0.6  1.3 ± 0.9  73.1 ± 7.4  74 ±  78.65 ± 5.3  81 ±  1.6 ± 1.1  1.3 ± 0.9
           Pressure   5.65 ± 3.9  6 ± 1.7  1.7 ± 0.6  2.05 ± 0.1  69.25± 6.3  63.1 ± 2.3  73.05 ± 5.7  78.5 ± 4.0  1.35 ± 1.9  0.75 ± 1.1
           bag
           Belmont
           Rapid   5.5 ± 3.0  6.1 ± 1.8  1.25 ± 0.8  1.2 ± 0.1  63.9 ± 7.7  60.7 ± 5.7  72.15 ± 7.5 79.9 ± 11.3  1.8± 0.1  1.9 ± 0.0
           Infuser
           Push­pull 6.35 ± 1.8  5.65 ± 4.3  1.6 ± 0.5  1.4 ± 0.8  66.05 ± 17.4 67.9 ± 42.9  76.2 ± 8.1  74.25± 56.5 0.85 ± 1.1 1.175 ± 1.3
          Data are expressed as mean ± standard deviation. All n values based on two subjects.
          α, measure of speed at which fibrin builds up and cross linking takes place; BL, baseline averages (three samples per subject); K, time taken to
          achieve a certain level of clot strength; Lys30, degree of fibrinolysis; M , ultimate strength of the clot; R, time of latency from the start of the test
                                                          a
          to initial fibrin formation; T+60, 60 minutes postinfusion (three samples per subject).
          TABLE 3  Pulmonary Pathology Findings              methodology differs in that we placed the IO access, flushed
                                  Pulmonary                  10mL of saline, and immediately began to transfuse. The pre­
                                   Arterial                  vious study delayed transfusion until 20 minutes after initial
                                  Fat Emboli   Fat Droplets/   IO insertion. Tactical Combat Casualty Care (TCCC) cur­
                                 (Histology or    10 HPF
              Transfusion Strategy  Oil Red O Stain) (Oil Red O Stain)  rently advocates for gravity as an IO transfusion strategy. This
           Gravity/pressure bag (UF)  0           18         practice is not supported by the findings of our pilot study.
                                                             TCCC instructors anecdotally have reported the resistance en­
           Gravity/pressure bag (LF)  0           15         countered before IO infusion as a “bone plug” that needs to
           Belmont Rapid Infuser (UF)  0           6         be cleared.  In our assessment of the bone matrix and effluent
                                                                     34
           Belmont Rapid Infuser (LF)  0          13         from the IO needle, we found no destruction of the matrix or
           Pressure bag single site (UF)  0        6         marrow content that suggested a bone plug. However, findings
           Pressure bag single site (LF)  0       26         in the literature support the TCCC recommendation of a 10–
           Pressure bag double site (UF)  0        8         20mL flush of normal saline before infusion. The physiologic
           Pressure bag double site (LF)  0       30         differences between systemic pressure and the pressure within
           Push­pull (UF)             0            8         the marrow is likely causal in the resistance encountered be­
                                                                                          6,35
           Push­pull (LF)             0           22         fore IO transfusion, not a bone plug.
          HPF, high­power field; LF, lower lung segment tissue sample; UF, up­
          per lung segment tissue sample.                    The major limitation of this pilot study is that it was not pow­
                                                             ered to detect differences in flow rate or hematologic, osseous,
          these juvenile animal models found no evidence of pulmonary   or pulmonary complications among the transfusion strategies.
          fat embolism. 8,10,11  In the current study, no evidence of pulmo­  We also lacked the logistic capability to evaluate rates of hemo­
          nary arterial fat embolism was found. However, in subjects in   lysis or renal inflammation as performed in prior research. 8,17
          each transfusion­strategy group, we did find varying degrees   Future research should include plasma­free hemoglobin to test
          of fat globules within the lung parenchyma.        for rates of hemolysis and be powered to detect these differ­
                                                             ences among transfusion strategies that vary by pressure and
          Research has suggested IO transfusion may result in pulmo­  anatomic site. Another limitation is that results from a swine
          nary fat embolism. 31–33  More recent research has described fat   model may not directly translate to humans. However, swine
          emboli from bone marrow intravasation, varying by degree of   have very similar bone, cardiovascular, and blood physiology,
                           33
          transfusion pressures.  However, these studies did not differ­  and serve as an excellent model for this type of research. 15,17
          entiate between pulmonary arterial fat emboli and presence   We  studied  whole  blood,  not  component  therapy,  which  is
          of fat globules within the lung parenchyma. This lack of dis­  more commonly used in DCR.  The use of fresh, whole blood
                                                                                     5
          tinction may account for the discrepancy within the literature.   is currently isolated to military operations and the results may
          Prior research noting fat emboli after IO transfusions has not   not be directly translatable to civilian trauma practice, where
          reported  corresponding physiologic  changes  consistent with   blood is transfused in a 1:1:1 ratio.  Another limitation is
                                                                                          36
          fat embolism syndrome. The only study following animals out   that the timed flow rate period in this study was limited to
                                                     8
          to 48 hours found no evidence of pulmonary fat emboli. Stud­  5 minutes. Flow rates may decrease the longer the infusion
          ies evaluating the effects of pressure IO transfusion strategies   is studied. The data established in this study were on warm,
          in skeletally mature pigs have found periosteal hemorrhage   fresh autologous whole blood and pertain only to the device
                                               27
          and scattered bone debris among their subjects.  We did not   and insertion sites studied. These data may not translate di­
          replicate these findings in our small pilot study.  rectly to cold, stored component therapy, other IO devices, or
                                                             insertion sites.
            Our study also differs from prior studies that used platelet, fi­
          brinogen, or plasma­free hemoglobin levels to determine rates   Conclusion
          of hemolysis secondary to transfusion. 8,17  We cannot com­
          ment  directly  on  hemolysis  among  our  strategies.  However,   IO blood transfusion by gravity alone cannot meet the require­
          we evaluated for clotting ability by testing TEG values and   ments for rDCR. The optimal strategy currently appears to be
          found no physiologically significant difference among strate­  IO blood transfusion with a 10–20mL flush of normal saline
          gies. We report a faster infusion rate than another study on IO   followed immediately by transfusion under 300mmHg via a
                                                     17
          blood transfusion in animals with higher bone density.  Our   pressure bag with a member of the resuscitation team inflating

          54  |  JSOM   Volume 18, Edition 3 / Fall 2018
   51   52   53   54   55   56   57   58   59   60   61